Press releases
- A Comparison of Vaccine Technologies to be Presented at the ASM Microbe Conference
- Soligenix Announces Reverse Stock Split
- Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting
- Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
- Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
- SuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX Conference
- Soligenix Encourages Stockholders to Vote Prior to Annual Meeting
- Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice
- Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results
- Soligenix to Present at Upcoming Conferences
More ▼
Key statistics
As of last trade Soligenix Inc (DOA0:BER) traded at 4.04, 0.00% below its 52-week high of 4.04, set on Jun 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 4.04 |
Low | 4.04 |
Bid | -- |
Offer | -- |
Previous close | 4.04 |
Average volume | -- |
---|---|
Shares outstanding | 987.49k |
Free float | 986.83k |
P/E (TTM) | -- |
Market cap | 3.42m USD |
EPS (TTM) | -11.83 USD |
Data delayed at least 15 minutes, as of Jun 06 2024 14:59 BST.
More ▼